Cell therapy plus immunotherapy for advanced solid tumors
Part of Cancer clinical trials.
This trial tests a combination of two cell-based therapies (SCTB41 and SCTB39-1) with or without standard cancer treatments for advanced solid tumors. The goal is to see if this approach helps slow or shrink tumors while being safe enough to use in patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed diagnosis of advanced solid cancer (not blood cancer)
- Your cancer has at least one measurable tumor that can be tracked on imaging
- You are between 18 and 75 years old and have a good enough health status to participate
- You have normal or near-normal organ and bone marrow function (shown by blood tests)
- You have not had other immunotherapy (except PD-1/PD-L1 drugs) or cancer treatment in the past 4 weeks
- You do not have cancer that has spread to your brain, spinal cord, or the lining of your brain
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called SCTB39-1 for people with advanced solid tumors that have not responded to other treatments. The study has two parts: first finding the right dose, then testing how well it works.
This trial tests a new drug called SCTB39G for people with advanced solid tumors that have not responded to other treatments. The goal is to see if it can help shrink or control the cancer.
This trial tests two experimental drugs (SCTB41 and SCTB39G), given with or without standard cancer therapies, for people with advanced solid tumors that have not responded to other treatments. The goal is to see if this combination is safe and effective.
This trial tests a new drug called SCTB41 in people with advanced solid tumors that have not responded to other treatments. The goal is to see if it is safe and if it shrinks tumors.
This trial tests a treatment that takes immune cells from your tumor, multiplies them in a lab, and gives them back to you to fight the cancer. It is for people with advanced solid tumors who have tried other treatments or cannot have them.
This trial tests a new immune cell therapy for people with advanced solid tumors of the lung, liver, colon, rectum, or breast. It aims to see if the treatment is safe and can help shrink or control the cancer.
Hear when a new Advanced Malignant Solid Neoplasm trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.